Reduction of cold-induced hypertension by antisense oligodeoxynucleotides to angiotensinogen mRNA and AT1-receptor mRNA in brain and blood

Hypertension

Volumn 31, Issue 6, 1998, Pages 1317-1323

  Peng, Jian Feng ^a   Kimura, Birgitta ^a   Fregly, Melvin J ^a   Phillips, M Ian ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin II; Angiotensinogen; Antisense elements; Hypertension, cold induced; Receptors; RNA

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; ANTISENSE OLIGODEOXYNUCLEOTIDE; MESSENGER RNA; OLIGODEOXYNUCLEOTIDE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLD INJURY; CONTROLLED STUDY; DOSE RESPONSE; DRINKING BEHAVIOR; DRUG MECHANISM; ESSENTIAL HYPERTENSION; HEART HYPERTROPHY; INTRACARDIAC DRUG ADMINISTRATION; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

EID: 0031810659     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.HYP.31.6.1317     Document Type: Article

References (26)

1. Gilson SB. Studies on adaptation to cold air in the rat. Am J Physiol. 1950;161:87-91.
2. Heroux PO, Dugal LP. Effet de l'acide ascortique sur l'hypertension experimentale. Can J Med Sci. 1951;29:164-175.
3. Fregly MJ. Effects of extremes of temperature on hypertensive rats. Am J Physiol. 1954;176:275-281.
4. Fregly MJ, Kikta DC, Threatte RM, Torres JL, Barney CC. Development of hypertension in rats during chronic exposure to cold. J Appl Physiol. 1989;66:741-749.
5. Fregly MJ, Rossi F, Van Bergen P, Brummermann M, Cade JR. Effect of chronic treatment with losartan potassium (Dup 753) on the elevation of blood pressure during chronic exposure of rats to cold. Pharmacology. 1993;46:198-205.
6. Shechtman O, Fregly MJ, Van Bergen P, Papanek PE. Prevention of cold-induced increase in blood pressure of rats by captopril. Hypertension. 1991;17:763-770.
7. Peng J-F, Fregly MJ, Phillips MI. The role of central and peripheral tissue renin-angiotensin system in cold-induced hypertension. Neurosci Soc. 1997;23:427. Abstract.
8. Fregly MJ, Shechtman O, Van Bergen P, Reeber C, Papanek PE. Changes in blood pressure and dipsogenic responsiveness to angiotensin II during chronic exposure of rats to cold. Pharmacol Biochem Behav. 1991;38:837-842.
9. Plunkett LM, Saavedra JM. Increased angiotensin II binding affinity in the nucleus tractus solitarius of spontaneously hypertensive rats. Proc Natl Acad Sci USA. 1985;82:7721-7724.
10. Phillips MI. Functions of angiotensin in the central nervous system. Ann Rev Physiol. 1987;49:413-435.
11. Gutkind JS, Kurihara M, Castren E, Saavedra JM. Increased concentration of angiotensin II binding sites in selected areas of the brain of spontaneously hypertensive rats. J Hypertens. 1988;6:79-84.
12. Gutkind JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol. 1988;255: H646-H650.
13. Wilson SK, Lynch DR, Latenson PW. Angiotensin II and atrial natriuretic factor-binding sites in various tissues in hypertension: comparative receptor localization and changes in different hypertension models in the rat. Endocrinology. 1989;124:2799-2808.
14. 1 receptor mRNA and angiotensinogen mRNA in the brain of spontaneously hypertensive rats reduces hypertension of neurogenic origin. Regul Pept. 1993; 49:167-174.
15. Phillips MI. Antisense inhibition and adeno-associated viral vector delivery for reducing hypertension. Hypertension. 1997;29:177-187.
16. Phillips MI, Wielbo D, Gyurko R. Antisense inhibition of hypertension: a new strategy for renin-angiotensin candidate genes. Kidney Int. 1994; 46:1554-1556.
17. Wielbo D, Sernia C, Gyurko R, Phillips MI. Antisense inhibition of hypertension in the spontaneously hypertensive rats. Hypertension. 1994;25:314-329.
18. Gyurko R, Tran D, Phillips MI. Time course of inhibition of hypertension by antisense oligonucleotides targeted to AT-1 angiotensin receptor mRNA in spontaneously hypertensive rats. Am J Hypertens. 1997;10:56S-62S.
19. Ohkubo H, Kageyama R, Ujihara M, Hirose T, Inayama S, Nakanishi S. Cloning and sequence analysis of cDNA for rat angiotensinogen. Proc Natl Acad Sci USA. 1983;80:2196-2200.
20. Murphy TJ, Alexander RW, Griending KK, Runge MS, Bernstein KE. Isolation of a cDNA encoding the vascular type-1 angiotensin II receptor. Nature. 1991;351:233-235.
21. 1 receptor. Regul Pept. 1995;59:171-182.
22. Fregly MJ. Induction of hypertension in rats exposed chronically to cold. In: Gertsberger R, ed. Integrative and Cellular Aspects of Autonomic Function. Paris, France: John Liberty Eurotext; 1994:201-208.
23. Morishita R, Gibbons GH, Ellison KE, Nakajima M, Zhang L, Kaneda Y, Ogihara T, Dzau VJ. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Proc Natl Acad Sci USA 1993;90:8474-8478.
24. 1 receptor antisense oligonucleotide inhibits central angiotensin-induced thirst and vasopressin. Regul Pept. 1994;54:543-551.
25. Sakai RR, He PF, Yang XD, Ma LY, Guo YF, Reilly JJ, Moga CN, Fluharty SJ. Intracerebroventricular administration of AT, receptor antisense oligonucleotide inhibits the behavioral actions of angiotensin II. J Neurochem. 1994;62:2053-2056.
26. Burgess T, Farrell C. The antiproliferative activity of c-myb and ac-myb antisense oligonucleotides in smooth muscle cells is caused by a non-antisense mechanism. Proc Natl Acad Sci USA. 1992;92: 4051-4055.